Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Dolastatin 10 mimic dolaphenine androstane

Sep. 13, 1996

Antitumor agents from Samjin

Sep. 13, 1996

Phase I trial of a new antiangiogenic agent from Daiichi

Sep. 13, 1996

Antiangiogenic eponemycin analogues

Sep. 13, 1996

The Liposome Company prepares and formulates new taxanes

Sep. 13, 1996

Improved camptothecin derivatives

Sep. 13, 1996

New multidrug resistance modulators

Sep. 6, 1996

Otsuka claims agents for cancer metastasis

Sep. 6, 1996

Promising results for lung cancer gene therapy

Sep. 6, 1996

Banyu discloses natural anticancer compounds

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...